Ohr Pharmaceutical Director Thomas Riedhammer receives $190K in 2013
Ohr Pharmaceutical reports 2013 executive compensation
By ExecPay News
Published: March 7, 2014
Ohr Pharmaceutical reported fiscal year 2013 executive compensation information on March 7, 2014.
In 2013, six executives at Ohr Pharmaceutical received on average a compensation package of $130K, a 50% decrease compared to previous year.
Thomas Riedhammer, Director, received $190K in total. 100% of Riedhammer's compensation, or $190K, was in option awards.
June Almenoff, Director, received a compensation package of $180K. 100% of the compensation package, or $180K, was in option awards.
Irach Taraporewala, Chief Executive Officer, earned $163K in 2013, a 72% decrease compared to previous year.
Sam Backenroth, Chief Financial Officer, received $131K in 2013, which decreases by 61% compared to 2012.
Ira Greenstein, Chairman, earned $58K in 2013, a 8% decrease compared to previous year.
Orin Hirschman, Director, received $58K in 2013, which decreases by 8% compared to 2012.